Loading clinical trials...
Loading clinical trials...
A Randomized Double-blind Controlled Study to Compare the Effectiveness of 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring
Conditions
Interventions
Alteplase
Locations
1
Canada
Windsor Regional Hospital
Windsor, Ontario, Canada
Start Date
October 1, 2014
Primary Completion Date
July 1, 2016
Completion Date
December 1, 2016
Last Updated
May 12, 2016
NCT07241390
NCT04634916
NCT06926660
NCT07271186
NCT06717698
NCT07454174
Lead Sponsor
University of Windsor
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions